Document Detail

Project onward: an innovative e-health intervention for cancer survivors.
MedLine Citation:
PMID:  22438297     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: This study examined the feasibility and acceptability of an Individual Internet Intervention (III) embedded and integrated into an Internet Support Group (ISG) with the ultimate goal of enhancing adherence and learning, compared with an individual internet invention alone.
METHOD: Thirty-one posttreatment cancer survivors were randomized in groups of seven to nine to either the 8-week III + ISG intervention or the 8-week III condition. Seventeen participants met the Hospital Anxiety and Depression Scale (HADS) criteria for depressive symptoms (HADS ≥ 8).
RESULTS: Among all participants, the mean number of logins over 8 weeks was 20.8 ± 17.7 logins for the III + ISG compared with 12.5 ± 12.5 in III-only (p = 0.15). Two participants in the III + ISG dropped out, compared with five in III (p = 0.39). Among the 17 participants with depressive symptoms at baseline, both the Onward and the III-only condition showed large reductions in the depression scale of HADS (d = 1.27 and 0.89, respectively). Improvement over time and time x treatment effects only reached trend significance levels (ps = 0.07 & 0.12) as this pilot was not powered to detect these differences.
CONCLUSION: Both the III + ISG and III-only demonstrated pre-post reductions in depressive symptoms and high rates of utilization compared with other web-based treatments for depression. Although it is premature to make any determination as to the efficacy of the interventions tested in this feasibility study, these results indicate that pursuing the III + ISG model, as well as standard IIIs, may be fruitful areas of future research.
Jennifer Duffecy; Stacy Sanford; Lynne Wagner; Mark Begale; Ewa Nawacki; David C Mohr
Related Documents :
22265857 - Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway ...
7744127 - Special considerations in the use of nsaids in the elderly.
21681017 - Addition of leukotriene receptor antagonists to inhaled corticosteroids improved qol of...
25221027 - Sy18-3efficacy of acamprosate for the treatment of alcohol dependence long after recove...
17873297 - Proteomic investigation of the ventral rat hippocampus links drp-2 to escitalopram trea...
2653297 - Outpatient myelography with iohexol and iopamidol; pilot study and contrast trial.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2012-03-21
Journal Detail:
Title:  Psycho-oncology     Volume:  22     ISSN:  1099-1611     ISO Abbreviation:  Psychooncology     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-04-08     Completed Date:  2013-09-25     Revised Date:  2014-09-22    
Medline Journal Info:
Nlm Unique ID:  9214524     Medline TA:  Psychooncology     Country:  England    
Other Details:
Languages:  eng     Pagination:  947-51     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Depression / psychology,  therapy*
Diffusion of Innovation
Feasibility Studies
Intervention Studies
Middle Aged
Neoplasms / psychology*,  therapy
Patient Compliance
Psychiatric Status Rating Scales
Quality of Life
Self-Help Groups
Socioeconomic Factors
Treatment Outcome
Grant Support
5 P30 CA60553-16/CA/NCI NIH HHS; P20 MH090318/MH/NIMH NIH HHS; P20 MH090318-01A1/MH/NIMH NIH HHS; R34 MH078922/MH/NIMH NIH HHS; R34 MH078922-03/MH/NIMH NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Breaking the Myth of the Recalcitrant Chemisorbed Hydrogens on Boron Niride Nanotubes: A Theoretical...
Next Document:  Exercise training counterbalances chronotropic incompetence and delayed heart rate recovery in syste...